The Fellow on Call: The Heme/Onc Podcast Episode 089: Prostate Cancer Series, Pt. 6- Treatment for Met. Castrate Sensitive Prostate Cancer
Jan 17, 2024
This podcast episode discusses the treatment options for metastatic castrate sensitive prostate cancer, including the lack of guidance and biomarkers for regimen selection. It also covers the importance of germline testing, the history of prostate cancer therapy, and the choice between doublet and triplet therapy. The hosts provide a case study and explore treatment options for high-volume, castrate-sensitive metastatic prostate cancer.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 4min
Thorough Discussion of a Patient with Very High-Risk Prostate Cancer and Metastatic Disease
03:47 • 4min
Evolution of Prostate Cancer Treatment
08:07 • 8min
Treatment for Met. Castrate Sensitive Prostate Cancer
16:31 • 5min
Treatment Options for High-Volume, Castrate-Sensitive Metastatic Prostate Cancer
21:22 • 5min